Crunelle D, Le Normand MT, Delfosse MJ [Oral and written language production in prematures children: results in 7 1/2-year-old]. Folia Phoniatr Logop. 2003 May-Jun;55(3):115-27. doi: 10.1159/000070723. French.
Marchman VA, Fernald A Speed of word recognition and vocabulary knowledge in infancy predict cognitive and language outcomes in later childhood. Dev Sci. 2008 May;11(3):F9-16. doi: 10.1111/j.1467-7687.2008.00671.x.
Marchman VA, Loi EC, Adams KA, Ashland M, Fernald A, Feldman HM Speed of Language Comprehension at 18 Months Old Predicts School-Relevant Outcomes at 54 Months Old in Children Born Preterm. J Dev Behav Pediatr. 2018 Apr;39(3):246-253. doi: 10.1097/DBP.00
Nishimura T, Takei N, Tsuchiya KJ, Asano R, Mori N Identification of neurodevelopmental trajectories in infancy and of risk factors affecting deviant development: a longitudinal birth cohort study. Int J Epidemiol. 2016 Apr;45(2):543-53. doi: 10.1093/ije
Sanchez K, Spittle AJ, Slattery JM, Morgan AT Oromotor Feeding in Children Born Before 30 Weeks' Gestation and Term-Born Peers at 12 Months' Corrected Age. J Pediatr. 2016 Nov;178:113-118.e1. doi: 10.1016/j.jpeds.2016.07.044. Epub 2016 Sep 5.
Spittle A, Orton J, Anderson PJ, Boyd R, Doyle LW Early developmental intervention programmes provided post hospital discharge to prevent motor and cognitive impairment in preterm infants. Cochrane Database Syst Rev. 2015 Nov 24;2015(11):CD005495. doi: 1
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
